Aziyo Biologics

company

About

Aziyo is a developer of customized tissue products intended to restore health and mobility to the greatest number of patients.

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$11.20M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2015
Number Of Employee
101 - 250
Operating Status
Active
Stock Symbol
nasdaq:AZYO
Legal Name
Aziyo Biologics, Inc.

Aziyo is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. From our proprietary tissue processing platforms, we have developed a portfolio of advanced regenerative medical products that are designed to be very similar to natural biological material.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
8
$109.28M
Aziyo Biologics has raised a total of $109.28M in funding over 2 rounds. Their latest funding was raised on Dec 15, 2022 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 15, 2022 Post-IPO Debt $4M 1 SWK Holdings Detail
Dec 1, 2022 Post-IPO Equity $11.20M Detail
Dec 6, 2021 Post-IPO Equity $14M Detail
Oct 8, 2020 IPO $50M Detail
Sep 11, 2020 Series Unknown $5.03M Detail

Investments

Number of Investments
Number of Lead Investments
5
0
Aziyo Biologics has made 5 investments. Their most recent investment was on Nov 16, 2022, when Virtualness raised $8M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 16, 2022 Virtualness
Seed $8M Information Technology
May 16, 2022 Smytten
Series B ₹1B Consumer
May 11, 2022 GoKwik
Series B $35M Artificial Intelligence
Feb 22, 2022 Slurrp Farm
Series Unknown ₹520M Food and Beverage
Oct 9, 2019 Smytten
Series A $1.50M Consumer

Investors

Number of Lead Investors
Number of Investors
2
4
Aziyo Biologics is funded by 4 investors. SWK Holdings and HighCape Partners are the most recent investors.
Investor Name Lead Investor Funding Round
SWK Holdings Yes Post-IPO Debt
HighCape Partners Yes Series Unknown
Deepfield Series Unknown
MidCap Financial Series Unknown

Employee Profiles

Number of Employee Profiles
6
Aziyo Biologics has 6 current employee profiles, including Executive Michelle LeRoux Williams